[1]
|
Agarwal, R., Sehgal, I.S., Dhooria, S., et al. (2020) Allergic Bronchopulmonary Aspergillosis. Indian Journal of Medi-cal Research, 151, 529-549. https://doi.org/10.4103/ijmr.IJMR_1187_19
|
[2]
|
温林芳, 刘双, 李梅, 徐晓峰, 刘羽佳, 常远. 变应性支气管肺曲霉病的治疗进展[J]. 中华内科杂志, 2019, 58(2): 150-153.
|
[3]
|
Ali, M. and Green, O.N. (2021) Dupilumab: A New Contestant to Corticosteroid in Allergic Bronchopulmonary Aspergillosis. Oxford Medical Case Reports, 2021, omaa029. https://doi.org/10.1093/omcr/omaa029
|
[4]
|
兰天飞, 王学艳, 王洪田. IgE与奥马珠单抗的研究进展[J]. 标记免疫分析与临床[J], 2021, 28(2): 343-347.
|
[5]
|
Zicari, A.M., Celani, C., De Cas-tro, G., Valerio De Biase, R. and Duse, M. (2014) Anti IgE Antibody as Treatment of Allergic Bronchopulmonary As-pergillosis in a Patient with Cystic Fibrosis. European Review for Medical and Pharmacological Sciences, 18, 1839-1841.
|
[6]
|
Mai, K.E. (2012) Management of Patients with Cystic Fibrosis and Allergic Bronchopulmonary As-pergillosis Using Anti-Immunoglobulin E Therapy (Omalizumab). The Journal of Pediatric Pharmacology and Thera-peutics, 17, 88-92.
https://doi.org/10.5863/1551-6776-17.1.88
|
[7]
|
Jacquelyn, M.Z. (2008) Steroid-Sparing Effect of Omalizumab for Allergic Bronchopulmonary Aspergillosis and Cystic Fibrosis. Pediatric Pulmonology, 43, 607-610. https://doi.org/10.1002/ppul.20804
|
[8]
|
肖幸幸, 韩国敬. 奥马珠单抗治疗变应性支气管肺曲霉菌病的临床疗效分析[J]. 临床肺科杂志, 2018, 23(12): 2219-2221.
|
[9]
|
马薇. 奥马珠单抗治疗变应性支气管肺曲霉菌病患者的临床疗效[J]. 中国药物经济学, 2020, 15(12): 87-89+92.
|
[10]
|
Agarwal, R., Chakrabarti, A., Shah, A., et al. (2013) Allergic Bronchopulmonary Aspergillosis: Review of Literature and Proposal of New Diagnostic and Classification Cri-teria. Clinical & Experimental Allergy, 43, 850-873.
https://doi.org/10.1111/cea.12141
|
[11]
|
Ashkenazi, M., Sity, S., Sarouk, I., et al. (2018) Omalizumab in Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis. Journal of Asthma and Allergy, 11, 101-107. https://doi.org/10.2147/JAA.S156049
|
[12]
|
Aydin, O., Sozener, Z.C., Soyyigit, S., et al. (2015) Omalizumab in the Treatment of Allergic Bronchopulmonary Aspergillosis: One Center’s Experience with 14 Cases. Allergy and Asthma Proceedings, 36, 493-500.
https://doi.org/10.2500/aap.2015.36.3909
|
[13]
|
Beam, K.T. and Coop, C.A. (2015) Steroid Sparing Effect of Omalizumab in Seropositive Allergic Bronchopulmonary Aspergillosis. Allergy & Rhinology, 6, 143-145. https://doi.org/10.2500/ar.2015.6.0128
|
[14]
|
Emiralioglu, N., Dogru, D., Tugcu, G.D., et al. (2016) Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis. Annals of Pharmacotherapy, 50, 188-193. https://doi.org/10.1177/1060028015624204
|
[15]
|
Galera, C., Pur Ozygit, L., Cavigioli, S., Bousquet, P.J. and De-moly, P. (2010) Gadoteridol-Induced Anaphylaxis—Not a Class Allergy. Allergy, 65, 132-134. https://doi.org/10.1111/j.1398-9995.2009.02137.x
|
[16]
|
Homma, T., Kurokawa, M., Matsukura, S., Yamaguchi, M. And Adachi, M. (2016) Anti-IgE Therapy for Allergic Bronchopulmonary Aspergillosis. Journal of Microbiology, Im-munology and Infection, 49, 459-463.
https://doi.org/10.1016/j.jmii.2013.10.003
|
[17]
|
Kanu, A. and Patel, K. (2008) Treatment of Allergic Bronchopul-monary Aspergillosis (ABPA) in CF with Anti-IgE Antibody (Omalizumab). Pediatric Pulmonology, 43, 1249-1251. https://doi.org/10.1002/ppul.20907
|
[18]
|
Koutsokera, A., Corriveau, S., Sykes, J., et al. (2020) Omalizumab for Asthma and Allergic Bronchopulmonary Aspergillosis in Adults with Cystic Fibrosis. Journal of Cystic Fibrosis, 19, 119-124.
https://doi.org/10.1016/j.jcf.2019.07.011
|
[19]
|
Lebecque, P., Leonard, A., Argaz, M., et al. (2009) Omalizumab for Exacerbations of Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis. BMJ Case Reports, 2009, bcr0720080379.
https://doi.org/10.1136/bcr.07.2008.0379
|
[20]
|
Lehmann, S., Pfannenstiel, C., Friedrichs, F., et al. (2014) Omali-zumab: A New Treatment Option for Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis. Thera-peutic Advances in Respiratory Disease, 8, 141-149.
https://doi.org/10.1177/1753465814547517
|
[21]
|
Lin, R.Y., Sethi, S. and Bhargave, G.A. (2010) Measured Immu-noglobulin E in Allergic Bronchopulmonary Aspergillosis Treated with Omalizumab. Journal of Asthma, 47, 942-945. https://doi.org/10.3109/02770903.2010.491144
|
[22]
|
Nathan, N., Girodon, E., Clement, A. and Corvol, H. (2012) A Rare CFTR Intronic Mutation Related to a Mild CF Disease in a 12-Year-Old Girl. BMJ Case Reports, 2012, bcr2012006918. https://doi.org/10.1136/bcr-2012-006918
|
[23]
|
Nove-Josserand, R., Grard, S., Auzou, L., et al. (2017) Case Series of Omalizumab for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis Patients. Pediatric Pulmonology, 52, 190-197. https://doi.org/10.1002/ppul.23612
|
[24]
|
O’reilly, A. and Dunican, E. (2021) The Use of Targeted Monoclonal Antibodies in the Treatment of ABPA-A Case Series. Medicina, 58, Article No. 53. https://doi.org/10.3390/medicina58010053
|
[25]
|
Perisson, C., Destruys, L., Grenet, D., et al. (2017) Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Young Patients with Cystic Fibrosis. Respiratory Medicine, 133, 12-15.
https://doi.org/10.1016/j.rmed.2017.11.007
|
[26]
|
Van Der Ent, C.K., Hoekstra, H. and Rijkers, G.T. (2007) Suc-cessful Treatment of Allergic Bronchopulmonary Aspergillosis with Recombinant Anti-IgE Antibody. Thorax, 62, 276-277. https://doi.org/10.1136/thx.2004.035519
|
[27]
|
Voskamp, A.L., Gillman, A., Symons, K., et al. (2015) Clinical Efficacy and Immunologic Effects of Omalizumab in Allergic Bronchopulmonary Aspergillosis. The Journal of Allergy and Clinical Immunology: In Practice, 3, 192-199.
https://doi.org/10.1016/j.jaip.2014.12.008
|
[28]
|
Wong, R., Wong, M., Robinson, P.D. and Fitzgerald, D.A. (2013) Omalizumab in the Management of Steroid Dependent Allergic Bronchopulmonary Aspergillosis (ABPA) Complicating Cystic Fibrosis. Paediatric Respiratory Reviews, 14, 22-24. https://doi.org/10.1016/j.prrv.2012.11.004
|
[29]
|
Agarwal, R., Muthu, V., et al. (2022) Allergic Bronchopulmonary Aspergillosis. Clinics in Chest Medicine, 43, 99-125.
https://doi.org/10.1016/j.ccm.2021.12.002
|
[30]
|
韩爽, 李远辉, 张健惠, 姚孟英. 78例变应性支气管肺曲霉病住院患者临床特征分析[J]. 中国实用医刊, 2021, 48(4): 1-3.
|
[31]
|
Agarwal, R., Khan, A., Garg, M., Aggarwal, A.N. and Gupta, D. (2012) Chest Radiographic and Computed Tomographic Manifestations in Allergic Bronchopulmonary Aspergillosis. World Journal of Radiology, 4, 141-150.
https://doi.org/10.4329/wjr.v4.i4.141
|
[32]
|
张龙举, 李竹, 刘晓丽. 变态反应性支气管肺曲菌病244例临床荟萃分析[J]. 中国全科医学, 2019, 22(23): 2880-2884.
|
[33]
|
Okayama, Y., Matsumoto, H., Odajima, H., et al. (2020) Roles of Omalizumab in Various Allergic Diseases. Allergology International, 69, 167-177. https://doi.org/10.1016/j.alit.2020.01.004
|